Antigen therapy eliminates T cell inflammation by apoptosis: Effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 4, 1997, Pages 1338-1343

  Weishaupt, Andreas ^a   Gold, Ralf ^a   Gaupp, Stefanie ^a   Giegerich, Gerhard ^a   Hartung, Hans Peter ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

neuritis; recombinant myelin proteins

Indexed keywords

GAMMA INTERFERON; MYELIN PROTEIN; OVALBUMIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; IMMUNIZATION; IMMUNOTHERAPY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; NEURITIS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SPLEEN; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNIZATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS; MYELIN P2 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

ANIMALIA;

EID: 0031036205     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.4.1338     Document Type: Article

References (22)

1. Hartung, H. P., Stell, G. & Toyka, K. V. (1993) in Peripheral Neuropathy, eds. Dyck, P. J., Thomas, P. K., Griffin, J. W., Low, P. A. & Poduslo, J. F. (Saunders, Philadelphia), p. 418
2. Brostoff, S. W., Levit, S. D. & Powers, J. M. (1977) Nature (London) 268, 752-753.
3. Kadlubowski, M. & Hughes, R. A. C. (1979) Nature (London) 277, 140-141.
4. Weishaupt, A., Giegerich, G., Jung, S., Gold, R., Enders, U., Potte, M., Hayasaka, K., Hartung, H.-P. & Toyka, K. V. (1995) J. Neuroimmunol. 63, 149-156.
5. Linington, C., Izumo, S., Suzuki, M., Uyemura, K., Meyermann, R. & Wekerle, H. (1984) J. Immunol. 133, 1946-1950.
6. Izumo, S., Linington, C., Wekerle, H. & Meyermann, R. (1985) Lab. Invest. 53, 209-218.
7. Heininger, K., Stoll, G., Linington, C., Toyka, K. V. & Wekerle, H. (1986) Ann. Neurol. 19, 44-49.
8. Critchfield, J. M., Racke, M. K., Zuniga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J. & Lenardo, M. J. (1994) Science 263, 1139-1143.
9. Wickham, E. A. (1996) Br. Med. J. 312, 988-989.
10. Zettl, U. K., Gold, R., Toyka, K. V. & Hartung, H.-P. (1995) J. Neuropathol. Exp. Neurol. 54, 540-547.
11. King, R. H. M., Craggs, R. I., Cross, M. L. P. & Thomas, P. K. (1985) Exp. Neurol. 87, 9-19.
12. Hartung, H. P., Schäfer, B., Heininger, K., Stoll, G. & Toyka, K. V. (1988) Brain 111, 1039-1059.
13. Gold, R., Schmied, M., Giegerich, G., Breitschopf, H., Hartung, H. P., Toyka, K. V. & Lassmann, H. (1994) Lab. Invest. 71, 219-225.
14. Klinkert, W. E. F. (1987) J. Immunol. 139, 1030-1036.
15. Zettl, U. K., Gold, R., Toyka, K. V. & Hartung, H.-P. (1996) Acta Neuropathol. 91, 360-367.
16. Pender, M. P., Nguyen, K. B., McCombe, P. A. & Kerr, J. F. (1991) J. Neurol. Sci. 104, 81-87.
17. Schmied, M., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H. & Lassmann, H. (1993) Am. J. Pathol. 143, 446-452.
18. Wekerle, H., Schwab, M., Linington, C. & Meyermann, R. (1986) Eur. J. Immunol. 16, 1551-1557.
19. McFarland, H. I., Critchfield, J. M., Racke, M. K., Mueller, J. P., Nye, S. H., Boehme, S. A. & Lenardo, M. J. (1995) in Immunobiology of Proteins and Peptides, eds. Atassi, M. Z. & Bixler, G. S., Jr., (Plenum, New York), Vol. 8, pp. 157-166.
20. Leist, M., Gantner, F., Jilg, S. & Wendel, A. (1995) J. Immunol. 154, 1307-1316.
21. Hafler, D. A. & Weiner, H. L. (1995) Immunol. Rev. 144, 75-107.
22. Haskins, K. & Wegmannn, D. (1996) Diabetes 45, 1299-1305.